Zepbound is not registered in Singapore; its medicine, tirzepatide, is registered here as Mounjaro (HSA register). GetLean prescribes Mounjaro where appropriate: S$488 monthly at 2.5 mg and 5 mg, S$788 at 7.5 mg and 10 mg, and S$1,088 at 15 mg, all-in. The first step is a S$20, 30-minute video consultation with Dr Quek.
The price covers Dr Quek's video consultations and reviews, the medication delivered to you, and daily WhatsApp coaching, and the first step is a 30-minute video consultation with Dr Quek for S$20, refunded in full if he decides medication is not right for you.
Availability in Singapore. Zepbound is not registered with Singapore's Health Sciences Authority, and GetLean does not supply any product sold as Zepbound; the grey-market guide covers products offered online outside the registered prescription route. Tirzepatide, its active ingredient, is registered here as Mounjaro, a prescription-only medicine. Which medicine suits a particular person, if any does, is decided by the doctor who assesses them.
Zepbound and Mounjaro: the same medicine
Zepbound and Mounjaro are both tirzepatide, made by Eli Lilly (Drugs@FDA; NDF), and they come in the same dose steps, 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg (Drugs@FDA; HSA register). Two things differ. The name: Zepbound is tirzepatide's weight-management application in the United States, approved on 8 November 2023, and it is not registered in Singapore, where tirzepatide's weight-management indication sits on its current Mounjaro registrations (Singapore NDF). And the label: Zepbound's United States label also covers obstructive sleep apnoea, which Singapore's registration does not (DailyMed). So what GetLean prescribes for weight loss is Mounjaro, when Dr Quek finds it clinically appropriate.
The name is not only American. In Japan, tirzepatide's obesity use is also marketed as Zepbound: Eli Lilly Japan lists Zepbound as tirzepatide (Eli Lilly Japan) and describes it as a medicine for obesity (Eli Lilly Japan). Singapore kept one name for both uses.
What does Singapore register instead of Zepbound?
Singapore registers tirzepatide as Mounjaro, including current products for weight management, while Zepbound has its own overseas registrations (HSA register; NDF).
| Name and jurisdiction | Registration and date | What the registration means here |
|---|---|---|
| Zepbound, United States | FDA weight-management approval 8 November 2023; sleep-apnoea supplement 20 December 2024 | Foreign approval; Zepbound is not on Singapore's register |
| Mounjaro, Singapore: original injection | First registered 1 March 2023 | Type 2 diabetes indication; not the current weight-management label |
| Mounjaro, Singapore: KwikPen and vial registrations | KwikPen 18 June 2025; vials 10 October 2025 | Current registrations include type 2 diabetes and weight management; Prescription Only |
Dates and classification: Drugs@FDA, HSA register. Indications: current NDF label, original label and US Zepbound label. GetLean does not supply any product sold as Zepbound. Its Mounjaro prices below describe the medicine actually prescribed here.
How does GetLean assess someone searching for Zepbound?
Dr Quek assesses whether a medicine registered here, such as Mounjaro, suits you; GetLean does not prescribe Zepbound.
- Book your consult. Tell us your health conditions, goals and any GLP-1 medication you take.
- Meet Dr Quek by video for 30 minutes. The first consultation is S$20. He decides suitability and which medicine, if any; a consultation does not guarantee a prescription.
- If he prescribes it, the medication is delivered to you, with daily WhatsApp coaching and Dr Quek's monthly reviews.
The GetLean GLP-1 programme includes the GetLean GLP-1 Taper Plan. For a comparison with semaglutide, Wegovy vs Mounjaro compares the registered weekly injections. Mounjaro side effects covers tirzepatide symptoms and the care-team contact route.
How much is Zepbound in Singapore?
At GetLean, Zepbound's medicine is prescribed as Mounjaro, and the monthly price follows the Mounjaro dose Dr Quek prescribes, with everything in it:
| Mounjaro dose (once weekly) | GetLean, per month, all-in |
|---|---|
| 2.5 mg | S$488 |
| 5 mg | S$488 |
| 7.5 mg | S$788 |
| 10 mg | S$788 |
| 15 mg | S$1,088 (max dose) |
| First video consultation with Dr Quek (30 minutes) | S$20, refunded in full if he decides medication is not right for you |
| After the taper: daily coaching and a monthly review, no medication | S$88, if you wish |
There is no Zepbound line in the table: Zepbound is not registered in Singapore, and GetLean does not supply it.
What the monthly price covers:
- Doctor video consultation and ongoing medical oversight by Dr Quek
- The medication, as prescribed, delivered discreetly to you
- A personalised nutrition and daily activity plan
- Daily WhatsApp coaching, and your care team on WhatsApp from 9am to 9pm every day, Singapore time. Outside those hours an urgent symptom does not wait for a reply: go to an emergency department, or call 995 if it is an emergency.
- Dose reviews that work toward your lowest effective dose
The price is set by the dose, so it can change at a monthly review: up to S$788 if Dr Quek steps the dose up past 5 mg (S$1,088 at 15 mg, the max dose), and back to S$488 as he steps it down during the taper. Which dose suits you, if any, is Dr Quek's decision at your consultation, and the pricing page sets out the whole programme. The Mounjaro page has the same table, with what the Singapore label says.
Book your consult with Dr Quek.
Zepbound offered online
Because Zepbound is not registered here, a pack labelled Zepbound offered for sale in Singapore has not been assessed by the Health Sciences Authority. Supplying a counterfeit, adulterated or tampered health product is an offence under the Health Products Act (Health Products Act), and HSA's own testing has found weight-loss products sold online to contain sibutramine, a drug disallowed in Singapore since 2010 because of its heart attack and stroke risk (HSA). On 25 September 2026 HSA warned that GLP-1 medicines, tirzepatide among them, are being touted on social media as quick fixes for weight loss, and that it has received reports of people hospitalised with severe vomiting after using GLP-1 medicines that came from overseas or online sources without a prescription or medical supervision (HSA 2026).
What does not travel: the sleep apnoea indication
Zepbound's United States label treats obstructive sleep apnoea (DailyMed). That indication belongs to the United States application. It is not part of tirzepatide's Singapore registration, which covers type 2 diabetes and weight management only (Singapore NDF). Headlines about the sleep apnoea approval describe the United States, not Singapore.
What happens when you stop Zepbound (tirzepatide)?
The same as stopping tirzepatide under any name: its effect fades over weeks. In SURMOUNT-4, adults switched to placebo after 36 weeks on tirzepatide regained 14.0% of body weight over the following year (Aronne 2024). Stepping down is a different picture: in SURMOUNT-MAINTAIN, adults who stepped down to a lower dose of tirzepatide after 60 weeks were still 16.6% below their starting weight a year later (Horn 2026).
At GetLean, the programme is designed to end, and our philosophy is that the medication is the catalyst and what you keep is the result. The plan for coming off is the GetLean GLP-1 Taper Plan: after hitting your goal weight with the right nutrition and exercise habits built, the dose is stepped down at Dr Quek's monthly reviews towards your lowest effective dose and, where clinically appropriate, off the medication. Individual results vary, and trial figures describe the populations studied. Never stop or change a prescribed medicine on your own. Coming off Mounjaro, week by week walks through those weeks.
Common questions
How much is Zepbound in Singapore?
At GetLean, tirzepatide is prescribed as Mounjaro: S$488 a month at 2.5 mg and 5 mg, S$788 a month at 7.5 mg and 10 mg, and S$1,088 a month at 15 mg (max dose), all-in: Dr Quek's video consultations and reviews, the medication delivered to you, and daily WhatsApp coaching. Zepbound is the same medicine under a United States name that is not registered in Singapore (HSA register), and GetLean does not supply it. The first video consultation is S$20, refunded in full if Dr Quek decides medication is not right for you.
Is Zepbound the same as Mounjaro?
Yes, the same medicine: both are tirzepatide, made by Eli Lilly, in the same dose steps from 2.5 mg to 15 mg (Drugs@FDA; HSA register). What differs is the name and the registration: Zepbound is a United States application of its own, approved on 8 November 2023, and is not registered in Singapore, where tirzepatide's weight-management indication sits on its current Mounjaro registrations (Singapore NDF).
Is Zepbound available in Singapore?
Not under that name. No product named Zepbound is registered in Singapore (HSA register). Its active ingredient, tirzepatide, is registered here under the name Mounjaro, and its current registrations include a weight-management indication (Singapore NDF); that is what GetLean prescribes, when Dr Quek finds it clinically appropriate.
Is Zepbound legal in Singapore?
Zepbound itself is not registered in Singapore, so no pack sold under that name here has been assessed by the Health Sciences Authority (HSA register). The same medicine, tirzepatide, is legal here on a doctor's prescription as Mounjaro, classified Prescription Only, and GLP-1 medicines may be dispensed only by a registered doctor or a licensed retail pharmacy against a valid prescription (MOH 2024).
Can a normal GP prescribe Mounjaro?
Yes, if they judge it appropriate after assessing you. Mounjaro is registered in Singapore and classified Prescription Only (HSA register), and GLP-1 medicines here may be dispensed only by a registered doctor or a licensed retail pharmacy, against a valid prescription (MOH 2024). At GetLean, Dr Quek assesses you at a video consultation and, if he finds it clinically appropriate, prescribes it and has it delivered to you, at the monthly prices on this page for the doses it lists.
Is Zepbound a long term solution?
Zepbound's US label covers reducing excess weight and maintaining weight reduction long term alongside diet and physical activity (DailyMed). That is a US indication, not a Singapore registration or a requirement that every patient stays on indefinitely. GetLean prescribes tirzepatide as Mounjaro, not Zepbound, and plans the dose reviews and GetLean GLP-1 Taper Plan from the first consultation; the duration is Dr Quek's decision at your reviews.
Does Zepbound's sleep apnoea approval apply in Singapore?
No. The sleep apnoea indication belongs to the United States Zepbound label (DailyMed), added by a supplement approved on 20 December 2024 (Drugs@FDA). An overseas approval is not a Singapore registration, and tirzepatide's Singapore indications are type 2 diabetes and weight management (Singapore NDF).
What about Zepbound sold online in Singapore?
A product that is not registered here has not been assessed by Singapore's Health Sciences Authority. Supplying a counterfeit or adulterated health product is an offence under the Health Products Act (Health Products Act), and HSA has found weight-loss products sold online to contain a drug banned in Singapore since 2010 (HSA).
Are GLP-1 agonists available in Singapore?
Yes, on a doctor's prescription. Tirzepatide is registered in Singapore as Mounjaro, and semaglutide as Wegovy, Ozempic and Rybelsus, all classified Prescription Only (HSA register); Zepbound is not among them.
How do I discuss tirzepatide with a doctor at GetLean?
Begin with a S$20, 30-minute video consultation with Dr Quek. He reviews your health history and goals and decides whether tirzepatide as Mounjaro is appropriate; GetLean does not prescribe Zepbound. If he prescribes it, medication is delivered with daily WhatsApp coaching and monthly reviews; a consultation does not guarantee a prescription.
Why do some Singapore pages call Mounjaro diabetes-only?
They may be describing the original 2023 injection registration, which carries type 2 diabetes only (NDF original label). The current KwikPen and vial registrations include weight management as well (NDF current label); an overseas Zepbound label is a separate registration again.
Is Zepbound only a United States name?
No. It is also the name used for tirzepatide's obesity product in Japan (Lilly Japan product information; Lilly Japan). Neither country's use of that name registers Zepbound in Singapore, where the registered tirzepatide name is Mounjaro (HSA register).
Which tirzepatide doses are on Singapore’s register?
Mounjaro's registered dose steps are 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg (HSA register). That is a registration list, not a GetLean stock or price list; the price table on this page names only the doses GetLean publishes. No product sold as Zepbound is supplied by GetLean.
Is Zepbound the same as Wegovy?
No. Zepbound contains tirzepatide, which acts at GIP and GLP-1 receptors (Jastreboff 2022); Wegovy contains semaglutide. In Singapore, those medicines are discussed as Mounjaro and Wegovy, the registered weight-management injections, rather than a local Zepbound product.
How much weight did people lose on tirzepatide in SURMOUNT-1?
In SURMOUNT-1, 2,539 adults were studied for 72 weeks; mean weight change was −15.0%, −19.5% and −20.9% on 5 mg, 10 mg and 15 mg against −3.1% on placebo (Jastreboff 2022). These are trial averages for tirzepatide, not a promised result or evidence of Zepbound availability in Singapore. Individual results vary and are not guaranteed.
What happens when Zepbound is stopped?
In SURMOUNT-4, adults switched to placebo after 36 weeks of tirzepatide regained 14.0% of body weight over the next year (Aronne 2024). At GetLean, tirzepatide is prescribed as Mounjaro, with coming off planned through the GetLean GLP-1 Taper Plan towards the lowest effective dose and, where clinically appropriate, off the medication. Individual results vary; never stop or change a prescribed medicine on your own.
Where should I read about tirzepatide side effects?
The Mounjaro side-effects page covers the tirzepatide product GetLean prescribes in Singapore. Zepbound's US label is a foreign label, including its sleep-apnoea indication (DailyMed); it does not create a Singapore prescription route. At GetLean, anything clinical goes to Dr Quek through the care team on WhatsApp.